bioRxiv / medRxiv
open access
Sodium channel blockers are associated with reduced dementia risk in late-onset unexplained epilepsy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A guide to neuromodulation in drug-resistant epilepsy.#481005
- Dihydropyridine Calcium Channel Blockers Amplify Gabapentin-Associated Dementia Risk: A Cohort Study#10128
- Chronic Kidney Disease Amplifies Gabapentin-Associated Dementia Risk: Evidence for a Renal Pharmacokinetic Mechanism#13915
- Efficacy Study of Intravenous Sodium Valproate in Addition to First Line Anti Epileptic Treatment of Generalized Convulsive Status Epilepticus.#913125
- Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy#674916
Record · ID 296511
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive